Table 1.
Summary of experimentally identified SARS‐CoV‐2 circRNAs
| Primer range | Subclone no. | circRNA no. | Representative circRNAs | Occurrence |
|---|---|---|---|---|
| 26198–>25546 | 1 | 1 | 26254 | 46, 77 | 25393 (#1)a | 1/1 |
| 27148–>26544 | 19 | 4 | 27283 | 47, 76 | 26480 (#5)a | 11/19 |
| 28533–>27671 | 3 | 3 | 28576 | 27555 (#7) | 1/3 |
| 28533–>27816 | 9 | 7 | 29195 | 27789 (#15) | 3/4c |
| 28576 | 27703 (#10) | 1/5d | |||
| 28642–>27816 | 12 | 6 | 29195 | 27789 (#15) | 6/6c |
| 28936–>27816 | 7 | 4 | 29195 | 27789 (#15) | 3/7 |
| 28576 | 27703 (#10) | 1/7 | |||
| 29083–>27893 | 10 | 3 | 29195 | 27789 (#15) | 6/10 |
| 28445–>28341 | 24 | 10 | 29122 | 28295 (#32)b | 12/24 |
| 29122 | 28320 (#33)b | 1/24 | |||
| 29045–>28443 | 9 | 4 | 29122 | 28295 (#32)b | 5/7d |
| 29122 | 28320 (#33)b | 2/7d | |||
| 28809–>28494 | 16 | 4 | 29122 | 28295 (#32)b | 3/4c |
| 28855 | 28434 (#38) | 7/11d | |||
| 28853 | 28467 (#37) | 4/11d | |||
| 28936–>28553 | 5 | 5 | 29122 | 28295 (#32)b | 1/5 |
| 29085 | 28321 (#41)b | 1/5 | |||
| 29045–>28953 | 21 | 20 | 29085 | 28321 (#41)b | 2/21 |
| 29122 | 28295 (#32)b | 1/21 | |||
| 29570–>39 | 3 | 1 | 29761 | 13 (#60) | 3/3 |
| 28445–>51 | 9 | 8 | 29015 | 13 (#65) | 2/9 |
| 29356–>51 | 5 | 2 | 29378 | 9 (#69) | 4/5 |
| 29761 | 13 (#60) | 1/5 | |||
| 29457–>51 | 3 | 3 | 29761 | 13 (#60) | 1/3 |
| 29572–>51 | 5 | 3 | 29761 | 13 (#60) | 2/5 |
| 29664 | 8 (#72) | 2/5 | |||
| 29668–>51 | 8 | 3 | 29761 | 13 (#60) | 6/8 |
Note: 169 subclones and 75 circRNAs were identified in total. Refer to Data S4 for details.
Abbreviations: circRNA, circular RNA; ORF, open reading frame; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2.
a
ORF‐containing circRNAs.
b
Fully assembled circRNAs.
c
From bands of low molecular weight.
d
From bands of high molecular weight.